That was page 5 from the Morgans note. The rest is not worth reading.
To be clear, the AEs do not concern me, it is the ability to effectively double blind the trial that got me thinking.
research reports and media, page-1566
-
- There are more pages in this discussion • 2,885 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.3¢ |
Change
0.008(3.33%) |
Mkt cap ! $81.36M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 24.0¢ | 22.5¢ | $147.8K | 636.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 81180 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 46740 | 1 |
View Market Depth
| Last trade - 15.56pm 13/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |